Search by Drug Name or NDC
NDC 42806-0513-30 QUINIDINE SULFATE 200 mg/1 Details
QUINIDINE SULFATE 200 mg/1
QUINIDINE SULFATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by EPIC PHARMA, LLC. The primary component is QUINIDINE SULFATE.
MedlinePlus Drug Summary
Quinidine is used to treat certain types of irregular heartbeats. Quinidine is in a class of medications called antiarrhythmic medications. It works by making your heart more resistant to abnormal activity.
Related Packages: 42806-0513-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Quinidine
Product Information
| NDC | 42806-0513 |
|---|---|
| Product ID | 42806-513_80df716e-b0d6-4b0f-b0f4-879874d7ed05 |
| Associated GPIs | 35100030300310 |
| GCN Sequence Number | 000222 |
| GCN Sequence Number Description | quinidine sulfate TABLET 200 MG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 01053 |
| HICL Sequence Number | 000075 |
| HICL Sequence Number Description | QUINIDINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | QUINIDINE SULFATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | quinidine sulfate tablet |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | QUINIDINE SULFATE |
| Labeler Name | EPIC PHARMA, LLC |
| Pharmaceutical Class | Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA088072 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42806-0513-30 (42806051330)
| NDC Package Code | 42806-513-30 |
|---|---|
| Billing NDC | 42806051330 |
| Package | 30 TABLET in 1 BOTTLE (42806-513-30) |
| Marketing Start Date | 2022-01-02 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.1705 |
| Pricing Unit | EA |
| Effective Date | 2022-04-06 |
| NDC Description | QUINIDINE SULFATE 200 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis